NMTC · NEUROONE MEDICAL TECHNOLOGIES Corp
$1.87
-0.07 (-3.61%)
At close · Aug 17
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern. The condensed financial statements do not include any adjustments that might result from the outcome of this condition.”View the 10-Q filed Aug 13, 2026
Market Cap
$17.67M
Shares
9.11M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-12-21 | 2025-08-15 | $6,750,000 | — | — | 10-Q , filed 2026-02-17 |
Key facts
CIK
1500198
CUSIP
64130M308
13F (30d)
25 filings
25 filers
Visit website
Investor relations